MPS-REGISTRATION FORM for MPS-CPDOnLine (Non MPS Member)

MPS Ordinary, Postgraduate, Associate Members (with Sub Paid Up Year 2018), Life and Fellow Members are automatically enrolled into the system. No further action is require to access the system.
MPS Members will also be able to access the Academy of Pharmacy E-Learning Programme website (www.acadpharm.org.my) besides the CPD-Online website (www.mps.org.my/cpdonline) with the same login name and password.
Non-MPS member need to register as below. Upon registration and payment of the fees, a login name and a password will be assigned to you. Please fill in your particulars below and send back to MPS either by post/fax/email (email to finance.mps@gmail.com & enter subject matter as “CPD-Enquiry and Registration-Your Name”. For eg: CPD-Enquiry and Registration-Adam.
Related
MPS-e-Learning Portal (CSCSP, Dengue, DMTAC, Erectile Dysfunction, Osteoporosis , Oral Contraceptives & Understanding Generic Medicines)
Last updated onMAP’s e-Learning Portal – Erectile Dysfunction (CPD Category A8: 3 Points) The aim of this course is to share existing evidence on the diagnosis and management of patients suffering from erectile dysfunction (ED). ED is one of the main growing complaints among males. This course is planned for healthcare providers as a self-study course and…
Remdesivir: Yay or Nay?
Last updated onManifesto MPS – Voices of Pharmacists
Last updated onDear fellow pharmacists, It is our duty as one of the 16,300 registered pharmacists to spread this message for the Malaysian General Elections 14 to be held on 9th May 2018. MPS has done it’s part to create this manifesto for the sake of the rakyat and the profession. We hope the in-coming government will…
[Update] Abolishment of Critical Allowance: What Really Happened
Last updated onThis is an update on the ongoing case regarding the abolishment of BIPK. To understand the background of the story, be sure to have a read at it here. Ever since the announcement of the abolishment of the critical allowance, the government has been subjected to endless public furore. Many stakeholders have since voiced…
FIPYPG’s 20th Anniversary
Last updated onMOH Statement on Influenza A
Last updated onOn 4 January, the Ministry of Health has released a document pertaining the influenza situation in Malaysia. There was an increase in Influenza-like illnesses (ILI) and admission of patients due to severe acute respiratory infection (SARI) since December 2019 in several parts of the nation. This might have caused panic and unrest amongst the Rakyat…
Others
Introductory Talk to the Tobacco Free Generation Concept
Last updated onSince our last article on COVID-19, so much has changed-the number of reported cases, better understanding of the virus’ characteristics, and its rebranding to COVID-19. After a harrowing month into the new decade, there’s finally some good news in 2020! This article will cover the rationale behind rebranding, latest statistics, and the roles of pharmacists…
National Antimicrobial Guideline 3rd Edition 2019
Last updated onHere is an update on the National Antimicrobial Guideline. This would be the third edition of the publication. “This update involved a structured and intensive discussion process to ensure that the content was carefully reviewed and coordinated for consistency,” wrote Datuk Dr Noor Hisham Abdullah, the Director General of Health. He also urged all Ministry…
On October 6, YPC held its annual innovative healthcare symposium for the third successive year. This year’s theme was ‘Healthcare 4.0: Closing the Gap Between Patients & Technology’. Via this platform, MPS-YPC hopes to increase awareness and interest in the advancement of technology in current healthcare settings. We had the honour of our very own…
Recall of Losartan
Last updated onOn early March, the Ministry of Health Malaysia released a statement regarding the recall of 7 types of medication containing the active ingredient Losartan. This came about after some of these angiotension II receptor blocker (ARB) were found to contain unacceptable amount of nitrosamine, a substance which is possibly carcinogenic, or has the potential to…
WHO to look into drug pricing?
Last updated onOur health ministry has urged the World Health Organisation (WHO) to look into drug pricing by major drug companies. This came about amidst the pressure on the ministry to utilise Compulsory Licensing (CL)* to gain access to generic versions of a Hepatitis C medication. “I hope the international community could look at how pharmaceutical companies…